Maven Securities LTD Eli Lilly & CO Transaction History

Maven Securities LTD

$774 Million
Q3 2024

A detailed history of Maven Securities LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Maven Securities LTD holds 2,885 shares of LLY stock, worth $2.1 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

2,885

Previous 3,555 18.85%

Holding current value

$2.1 Million

Previous $3.22 Million 20.6%

% of portfolio

0.33%

Previous 0.55%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $517,333 - $643,213	-670 Reduced 18.85%	2,885 $2.56 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $2.34 Million - $2.94 Million	-3,234 Reduced 47.64%	3,555 $3.22 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $2.44 Million - $3.26 Million	4,113 Added 153.7%	6,789 $5.28 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $1.41 Million - $1.66 Million	2,676 New	2,676 $1.56 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $764,613 - $1.02 Million	2,180 New	2,180 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $196,467 - $228,923	611 Added 47.33%	1,902 $695,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $5,336 - $6,081	18 Added 1.41%	1,291 $4.17 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $354,823 - $416,614	1,273 New	1,273 $413,000
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $233,281 - $289,910	-994 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $55,537 - $68,922	-247 Reduced 19.9%	994 $275,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $275,005 - $338,433	1,241 New	1,241 $287,000
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $191,021 - $247,085	-1,058 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $173,850 - $225,057	1,058 New	1,058 $198,000

Others Institutions Holding LLY

# of Institutions

4,002

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $691B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Account

Maven Securities LTD Eli Lilly & CO Transaction History